Meningitis outbreak stirs calls for FDA pharmacy oversight
Democratic lawmakers said the new crisis showed it was time for Congress to strengthen the FDA's hand in overseeing this side of the drug industry. There was no immediate comment from Republican members of Congress, who tend to favor deregulation.
Deadly Meningitis Outbreak Highlights The Need For Strengthened FDA …
Compounding Crisis Spotlights Regulatory Confusion
Should FDA get more power over compounding pharmacies?